Qiao Yan, Tao Zhaoyu, Hao Feiran, Huang Yongqiang, Sun Hong, Guo Pu
Department of Infectious Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233004, People's Republic of China.
Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
Infect Drug Resist. 2023 Jul 21;16:4769-4778. doi: 10.2147/IDR.S411283. eCollection 2023.
is one of the most important pathogens of hospital-acquired bloodstream infections. Its morbidity and mortality are still high, which is a serious global public problem.
To investigate the strain distribution, drug susceptibility, clinical characteristics of patients, and risk factors affecting the prognosis of bloodstream infection (BSI).
We retrospectively collected the clinical data, infection-related indicators, prognosis, strain prevalence and drug susceptibility of 163 patients with BSI in a teaching hospital from January 2012 to December 2022. Univariate and multivariate logistic regression were used to analyze the risk factors affecting the prognosis.
In 163 cases of BSI, accounted for 48.47%, and non accounted for 51.53%. A total of 163 patients with BSI were mainly distributed in intensive care unit (ICU) and emergency department, accounting for 40.49% and 14.72%, respectively. The resistance rate of to fluconazole, itraconazole and voriconazole was less than 10%, and the sensitivity rate of to fluconazole, itraconazole and voriconazole was less than 80%. The mortality rate of 163 patients with BSI was 33.13%, with non- higher than that of ( = 0.04). Multivariate analysis showed that hemodialysis (OR = 0.199, 95% CI: 0.059-0.673, = 0.009), arteriovenous catheters (OR = 0.344, 95% CI: 0.130-0.913, = 0.032), elevated neutrophil count (OR = 0.409, 95% CI: 0.194-0.862, = 0.019) and APACHE II score ( = 0.848, 95% CI: 0.789~0.911, < 0.001) were independent risk factors for death in patients with candidemia.
The blood flow infection rate of non- is increasing, and the mortality rate and resistance to antifungal drugs are higher than that of . Hemodialysis, arteriovenous catheters, elevated neutrophil count and APACHE II score were associated with death in patients with BSI.
是医院获得性血流感染最重要的病原体之一。其发病率和死亡率仍然很高,是一个严重的全球公共问题。
调查血流感染(BSI)的菌株分布、药敏情况、患者临床特征及影响预后的危险因素。
回顾性收集2012年1月至2022年12月某教学医院163例BSI患者的临床资料、感染相关指标、预后、菌株流行情况及药敏情况。采用单因素和多因素logistic回归分析影响预后的危险因素。
163例BSI中,占48.47%,非占51.53%。163例BSI患者主要分布在重症监护病房(ICU)和急诊科,分别占40.49%和14.72%。对氟康唑、伊曲康唑和伏立康唑的耐药率低于10%,对氟康唑、伊曲康唑和伏立康唑的敏感率低于80%。163例BSI患者的死亡率为33.13%,非的死亡率不高于(=0.04)。多因素分析显示,血液透析(OR=0.199,95%CI:0.059-0.673,=0.009)、动静脉导管(OR=0.344,95%CI:0.130-0.913,=0.032)、中性粒细胞计数升高(OR=0.409,95%CI:0.194-0.862,=0.019)和APACHE II评分(=0.848,95%CI:0.789~0.911,<0.001)是念珠菌血症患者死亡的独立危险因素。
非的血流感染率在上升,其死亡率和对抗真菌药物的耐药性高于。血液透析、动静脉导管、中性粒细胞计数升高和APACHE II评分与BSI患者死亡有关。